OnCore Login

Return to Trial Database

GU12-159

The Pacific Clinical Trial: A Randomized Phase II Study Evaluating OGX-427 in Patients With Metastatic Castrate-Resistant Prostate Cancer (MCRPC)Who Have Prostate-Specific Antigen (PSA) Progression While Receiving Abiraterone: Hoosier Oncology Group GU12-159

Status

Study Completed

Cancer Type(s)

Prostate

Study Contact

Publications

PACIFIC trial: A randomized phase II study of apatorsen and abiraterone in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) who have had PSA progression while receiving abiraterone (ABI)
  • KN Chi, MT Fleming, K Sunderland, C Albany, J Gingerich, F Saad, SA North, A Starodub, RC Lauer, JD Ruether, MM Sgroi, MC Scholz, C Sweeney

Trial Locations

All sites in which the trial GU12-159 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278